Inhaler
Latest Novartis AG Patents:
- NMDA receptor modulators and uses thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
- CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
- CD19 and CD22 chimeric antigen receptors and uses thereof
- ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D579546
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,807
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,807
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)